Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

This study is currently recruiting participants.

Verified by University of Alabama at Birmingham, January 2008

First Received: January 24, 2008 Last Updated: February 6, 2008 History of Changes

Sponsor:	University of Alabama at Birmingham
Information provided by:	University of Alabama at Birmingham
ClinicalTrials.gov Identifier:	NCT00609726

Purpose

The purpose of the study is to determine the best evaluation for patients with idiopathic (unexplained) pancreatitis, we are evaluating the role of endoscopic ultrasonography given that this minimally invasive study can diagnose gallbladder disease as well as pancreatic abnormalities.

Condition
Gallbladder Disease Pancreatitis

Study Type:	Observational
Study Design:	Case Control, Prospective
Official Title:	Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

Resource links provided by NLM:

MedlinePlus related topics: Endoscopy Gallbladder Diseases Ultrasound

U.S. FDA Resources

Further study details as provided by University of Alabama at Birmingham:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	100
Study Start Date:	October 2004
Estimated Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	19 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Men and women diagnosed with unexplained pancreatitis.

Criteria

Inclusion Criteria:

All patients referred to the principal investigator for unexplained pancreatitis will be enrolled.

Exclusion Criteria:

There are no gender nor racial exclusion.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00609726

Contacts

Contact: Charles M Wilcox, M.D.

205-975-4958

Locations

United States, Alabama
University of Alabama	Recruiting
Birmingham, Alabama, United States, 35294

Sponsors and Collaborators

University of Alabama at Birmingham

Investigators

Principal Investigator:

Charles M Wilcox, M.D.

University of Alabama at Birmingham

More Information

No publications provided

Responsible Party:	University of Alabama ( Dr. Charles Mel Wilcox, M.D. )
Study ID Numbers:	X040909004, 228552
Study First Received:	January 24, 2008
Last Updated:	February 6, 2008
ClinicalTrials.gov Identifier:	NCT00609726 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:

Identifying patients with gallbladder disease by EUS not picked up on routine studies and thus patients these patients have avoided ERCP.

Additional relevant MeSH terms:

Gallbladder Diseases
Digestive System Diseases
Biliary Tract Diseases
Pancreatic Diseases
Pancreatitis

ClinicalTrials.gov processed this record on November 05, 2009